MedTrace Logo

Efficacy of Spinal Oxytocin in Healthy Volunteers

NCT01996605 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2023-09-14

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine the effect of intrathecal oxytocin on areas and intensity of hyperalgesia and allodynia induced by topical capsaicin.

Conditions

  • Healthy Volunteer Study

Interventions

DRUG

Oxytocin 15 mcg

Oxytocin 15 mcg will be administered spinally

DRUG

Oxytocin 150 mcg

Oxytocin 150 mcg will be administered spinally

DRUG

Placebo

placebo will be administered spinally

Sponsors & Collaborators

  • Wake Forest University Health Sciences

    lead OTHER

Principal Investigators

  • James C Eisenach, MD · Wake Forest University Health Sciences

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
59 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-01-02
Primary Completion
2022-10-10
Completion
2022-10-10
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01996605 on ClinicalTrials.gov